Kensey Nash Corporation, a prominent player in the medical device industry, is headquartered in the United States. Founded in 1995, the company has established itself as a leader in the development of innovative biomaterials and medical technologies, particularly in the fields of orthopaedics and cardiovascular solutions. With a strong focus on research and development, Kensey Nash offers a range of unique products, including resorbable scaffolds and advanced wound care solutions, designed to enhance patient outcomes. The company has achieved significant milestones, including numerous patents and collaborations with major healthcare providers, solidifying its market position. Kensey Nash's commitment to quality and innovation has earned it recognition as a trusted partner in the medical community, making it a key contributor to advancements in healthcare technology.
How does Kensey Nash Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Kensey Nash Corporation's score of 92 is higher than 96% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Kensey Nash Corporation, headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of DSM-Firmenich AG, which influences its climate commitments and emissions reporting. As part of its corporate family relationship, Kensey Nash Corporation inherits climate initiatives and targets from DSM-Firmenich AG. This includes participation in various sustainability frameworks such as the Science Based Targets initiative (SBTi), CDP, and RE100, all of which are cascaded from DSM-Firmenich AG. However, specific reduction targets or achievements for Kensey Nash Corporation have not been disclosed. While Kensey Nash Corporation has not published its own emissions data or reduction targets, it aligns with the broader sustainability goals set by its parent company, DSM-Firmenich AG. This alignment indicates a commitment to reducing carbon emissions and enhancing climate resilience, although specific metrics and timelines remain unspecified.
Access structured emissions data, company-specific emission factors, and source documents
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 1,030,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | - | 000,000,000 | 000,000,000 | 000,000,000 | 
| Scope 2 | 590,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 0,000,000 | - | 000,000,000 | 000,000,000 | 000,000,000 | 
| Scope 3 | 8,683,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | - | 00,000,000,000 | 0,000,000,000 | 00,000,000,000 | 00,000,000,000 | 
Kensey Nash Corporation's Scope 3 emissions, which increased by 7% last year and increased by approximately 28% since 2016, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 75% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Kensey Nash Corporation has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.